Showing results (791-800 of 1,427) with videos related to

Sort By:
Pageof 143
Documenta Ophthalmologica. Advances in Ophthalmology|January 29, 2021
Dark-adapted threshold and electroretinogram for diagnosis of Usher syndromeLucia Ambrosio, Ronald M Hansen, Anne Moskowitz, et al.
Surgical Endoscopy|November 30, 2021
Long-term outcomes of endoscopic mucosal resection for early-stage esophageal adenocarcinomaKesha Oza, Tejasvi Peesay, Benjamin Greenspun, et al.
Journal of Drugs in Dermatology : JDD|April 14, 2021
Treatment of Impetigo and Antimicrobial ResistanceLawrence A Schachner, Charles W Lynde, Leon H Kircik, et al.
International Journal of Molecular Sciences|February 25, 2023
The Role of Red Cell Distribution Width as a Prognostic Marker in Chronic Liver Disease: A Literature ReviewHunain Aslam, Fouzia Oza, Khalid Ahmed, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|August 16, 2024
Accuracy of Patient-Collected Vital SignsJoshua P Metlay, Ralph Gonzales, Timothy J Judson, et al.
Indian Journal of Endocrinology and Metabolism|October 7, 2024
A Comparative Study of Bone-Health and Associated Factors in Healthy Indian Adolescents and Young WomenNeha A Kajale, Chirantap Oza, Dipali Ladkat, et al.
British Journal of Cancer|September 1, 1990
High dose cytosine arabinoside in the initial treatment of adults with acute lymphoblastic leukaemiaA Z Rohatiner, R Bassan, R Battista, et al.
American Journal of Perinatology|August 23, 2008
Hemolytic disease of the fetus and newborn due to anti-Ge3: combined antibody-dependent hemolysis and erythroid precursor cell growth inhibitionDouglas P Blackall, Gina D Pesek, Matthew M Montgomery, et al.
Investigational New Drugs|March 15, 2011
A phase II trial of the Src kinase inhibitor saracatinib (AZD0530) in patients with metastatic or locally advanced gastric or gastro esophageal junction (GEJ) adenocarcinoma: a trial of the PMH phase II consortiumHelen J Mackay, Heather J Au, Elaine McWhirter, et al.
Gynecologic Oncology|April 16, 2003
Phase II study of CGP 69846A (ISIS 5132) in recurrent epithelial ovarian cancer: an NCIC clinical trials group study (NCIC IND.116)A M Oza, L Elit, K Swenerton, et al.
Pageof 143